K2 or Spice Test Evidence
Has Caused a False Positive
Lamotrigine
Source Kurku et al., Scand J Clin Lab Invest 2021
What It Found
- Urine from lamotrigine users showed a K2/1 signal despite negative targeted LC-MS/MS.
- Adding lamotrigine or user urine reproduced the interference.
Keep in Mind
- This assay targets synthetic cannabinoid metabolites such as those of JWH-018.
- Its findings do not establish interference on a conventional marijuana test.
Test Studied
- K2/1 synthetic cannabinoid metabolite homogeneous enzyme immunoassay
A Related Drug the Test Picks Up
JWH-122
Source Kronstrand et al., Anal Bioanal Chem 2014
What It Found
- The assay recognized metabolites of JWH-122 while it failed to recognize the tested UR-144 metabolites.
Keep in Mind
- This dedicated synthetic-cannabinoid test differs from a routine THC screen.
- The named metabolites and antibody target matter.
Test Studied
- Synthetic-cannabinoid urine immunoassay with LC-QTOF-MS confirmation
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The antibody recognized JWH-122 or specific metabolites in the urine challenge table.
- For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.
Keep in Mind
- Specific antibodies and the actual metabolite determine the result.
- This assay is distinct from conventional urine THC testing.
Test Studied
- NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA
MAM-2201
Source Kronstrand et al., Anal Bioanal Chem 2014
What It Found
- The assay recognized metabolites of MAM-2201 while it failed to recognize the tested UR-144 metabolites.
Keep in Mind
- This dedicated synthetic-cannabinoid test differs from a routine THC screen.
- The named metabolites and antibody target matter.
Test Studied
- Synthetic-cannabinoid urine immunoassay with LC-QTOF-MS confirmation
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The antibody recognized MAM-2201 or specific metabolites in the urine challenge table.
- For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.
Keep in Mind
- Specific antibodies and the actual metabolite determine the result.
- This assay is distinct from conventional urine THC testing.
Test Studied
- NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA
AM-1220
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The antibody recognized AM-1220 or specific metabolites in the urine challenge table.
- For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.
Keep in Mind
- Specific antibodies and the actual metabolite determine the result.
- This assay is distinct from conventional urine THC testing.
Test Studied
- NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA
AM-2201
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The antibody recognized AM-2201 or specific metabolites in the urine challenge table.
- For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.
Keep in Mind
- Specific antibodies and the actual metabolite determine the result.
- This assay is distinct from conventional urine THC testing.
Test Studied
- NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA
JWH-018
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The antibody recognized JWH-018 or specific metabolites in the urine challenge table.
- For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.
Keep in Mind
- Specific antibodies and the actual metabolite determine the result.
- This assay is distinct from conventional urine THC testing.
Test Studied
- NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA
JWH-019
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The antibody recognized JWH-019 or specific metabolites in the urine challenge table.
- For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.
Keep in Mind
- Specific antibodies and the actual metabolite determine the result.
- This assay is distinct from conventional urine THC testing.
Test Studied
- NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA
JWH-073
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The antibody recognized JWH-073 or specific metabolites in the urine challenge table.
- For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.
Keep in Mind
- Specific antibodies and the actual metabolite determine the result.
- This assay is distinct from conventional urine THC testing.
Test Studied
- NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA
JWH-200
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The antibody recognized JWH-200 or specific metabolites in the urine challenge table.
- For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.
Keep in Mind
- Specific antibodies and the actual metabolite determine the result.
- This assay is distinct from conventional urine THC testing.
Test Studied
- NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA
JWH-398
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The antibody recognized JWH-398 or specific metabolites in the urine challenge table.
- For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.
Keep in Mind
- Specific antibodies and the actual metabolite determine the result.
- This assay is distinct from conventional urine THC testing.
Test Studied
- NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA
The Test Is Made to Find It
UR-144
Source Kronstrand et al., Anal Bioanal Chem 2014
What It Found
- The assay did not recognize the tested metabolites of UR-144, a synthetic cannabinoid.
Test Studied
- A synthetic-cannabinoid urine immunoassay compared with LC-QTOF-MS
Source Mohr et al., J Anal Toxicol 2014
What It Found
- This dedicated assay recognized hydroxylated UR-144 and XLR-11 metabolites more strongly than the parent drugs.
- Parent-drug cross-reactivity was below 10%.
Keep in Mind
- This describes the intended test and targets.
- It does not imply a positive standard THC screen.
Test Studied
- Urine ELISA designed specifically to detect UR-144 and XLR-11, compared with LC-MS/MS
2 sources Mohr et al., J Anal Toxicol 2014 Barnes et al., Ther Drug Monit 2015
What It Found
- The NMS antibody showed negligible or absent recognition of the tested UR-144 material, in contrast to a test designed specifically to identify UR-144/XLR-11.
2 sources Kronstrand et al., Anal Bioanal Chem 2014 Mohr et al., J Anal Toxicol 2014
Keep in Mind
- Other specific synthetic-cannabinoid assays can be designed to recognize UR-144 metabolites.
All 3 sources Kronstrand et al., Anal Bioanal Chem 2014 Mohr et al., J Anal Toxicol 2014 Barnes et al., Ther Drug Monit 2015
Keep in Mind
- The compounds are genuine synthetic cannabinoids, but screening tests cover different structures.
Source Barnes et al., Ther Drug Monit 2015
Test Studied
- NMS synthetic-cannabinoid JWH-018 metabolite ELISA
XLR-11
Source Mohr et al., J Anal Toxicol 2014
What It Found
- This dedicated assay recognized hydroxylated UR-144 and XLR-11 metabolites more strongly than the parent drugs.
- Parent-drug cross-reactivity was below 10%.
Keep in Mind
- This describes the intended test and targets.
- It does not imply a positive standard THC screen.
Test Studied
- Urine ELISA designed specifically to detect UR-144 and XLR-11, compared with LC-MS/MS
Both sources Mohr et al., J Anal Toxicol 2014 Barnes et al., Ther Drug Monit 2015
What It Found
- The NMS antibody showed negligible or absent recognition of the tested XLR-11 material, in contrast to a test designed specifically to identify UR-144/XLR-11.
Keep in Mind
- The compounds are genuine synthetic cannabinoids, but screening tests cover different structures.
Source Barnes et al., Ther Drug Monit 2015
Test Studied
- NMS synthetic-cannabinoid JWH-018 metabolite ELISA
Suspected, but Not Proven
Buprenorphine
Source Barnes et al., Forensic Sci Int 2014
What It Found
- A mixture of buprenorphine and norbuprenorphine, each at 1,000 ng/mL, gave a K2 Spice response of 7.3 ng/mL.
- That crossed the investigators’ proposed 5 ng/mL cutoff but stayed below the manufacturer’s 10 ng/mL cutoff.
Keep in Mind
- The first experiment cannot tell whether buprenorphine itself, its metabolite, or their combination accounted for the signal.
Test Studied
- Immunalysis K2 Spice urine homogeneous enzyme immunoassay
Source Barnes et al., Ther Drug Monit 2015
What It Found
- On the separate NMS ELISA, challenges including both compounds at 1,000 ng/mL did not produce a positive or appreciably suppress the 5 ng/mL control.
Test Studied
- NMS urine ELISA targeting a JWH-018 metabolite
Both sources Barnes et al., Forensic Sci Int 2014 Barnes et al., Ther Drug Monit 2015
Keep in Mind
- Neither study establishes a positive screening result after someone takes buprenorphine.
- The findings concern dedicated synthetic-cannabinoid screens.
Tested: No False Positive Found
2C-B
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with 2C-B.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
6-Acetylcodeine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with 6-acetylcodeine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Acetaminophen
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with acetaminophen.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Alprazolam
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with alprazolam.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Amphetamine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with amphetamine and p-hydroxyamphetamine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- The paper identifies the standard as amphetamine without specifying an isomer or testing a marketed formulation.
- It also tested the named hydroxy metabolite.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Aspirin
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with acetylsalicylic acid.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
BDB
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with BDB.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Bromazepam
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with bromazepam.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Brompheniramine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with brompheniramine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Caffeine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with caffeine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Cannabidiol
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with cannabidiol.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Cannabigerol
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with cannabigerol.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Cannabinol
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with cannabinol.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Cathinone
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with cathinone.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Chlorpheniramine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with chlorpheniramine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Clomipramine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with clomipramine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Clonazepam
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with clonazepam and 7-aminoclonazepam.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Clonidine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with clonidine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Cocaethylene
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with cocaethylene and norcocaethylene.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Cocaine (medical topical use)
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with cocaine, benzoylecgonine, norcocaine, ecgonine, norbenzoylecgonine, ecgonine ethyl ester, ecgonine methyl ester, anhydroecgonine methyl ester and the tested hydroxylated metabolites.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- These were chemical standards.
- The study did not test urine following topical medical cocaine administration.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Codeine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with codeine and norcodeine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Dextromethorphan
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with dextromethorphan.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Diazepam
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with diazepam and nordiazepam.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Diphenhydramine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with diphenhydramine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Dronabinol
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with THC, 11-hydroxy-THC and THC-COOH.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- The study used THC and its metabolites as chemical standards.
- It did not test urine collected after dronabinol dosing.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Ephedrine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with ephedrine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Ethylamphetamine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with ethylamphetamine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Flunitrazepam
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with flunitrazepam and 7-aminoflunitrazepam.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Fluoxetine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with fluoxetine and norfluoxetine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Flurazepam
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with flurazepam.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Heroin
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with 6-acetylmorphine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Only the heroin metabolite 6-acetylmorphine (6-MAM) was tested.
- The experiment gives no direct result for the parent drug.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Hydrocodone
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with hydrocodone.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Ibuprofen
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with ibuprofen.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Imipramine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with imipramine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Ketamine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with ketamine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Lorazepam
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with lorazepam.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
MBDB
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with MBDB.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
MDA
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with MDA.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
MDEA
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with MDEA.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
MDMA
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with MDMA and its HMA and HMMA derivatives.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Methadone
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with methadone, EDDP and EMDP.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Methamphetamine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with methamphetamine and p-hydroxymethamphetamine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Morphine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with morphine, normorphine and morphine-3- and morphine-6-glucuronide.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Nicotine replacement therapy
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with nicotine, cotinine, norcotinine and trans-3′-hydroxycotinine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- These were chemical standards.
- The study did not test urine after use of a nicotine patch, gum or other replacement product.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Nitrazepam
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with nitrazepam and 7-aminonitrazepam.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Oxazepam
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with oxazepam.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Oxycodone
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with oxycodone and noroxycodone.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Oxymorphone
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with oxymorphone and noroxymorphone.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Paroxetine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with paroxetine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Pentazocine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with pentazocine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Phentermine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with phentermine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
PMA
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with p-methoxyamphetamine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
PMMA
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with p-methoxymethamphetamine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Propoxyphene
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with propoxyphene.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Pseudoephedrine
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with pseudoephedrine.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite
Temazepam
Source Barnes et al., Ther Drug Monit 2015
What It Found
- The researchers challenged the assay with temazepam.
- At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.
Keep in Mind
- Laboratory challenge on this dedicated synthetic-cannabinoid assay.
- The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.
Test Studied
- NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite